19 hours FDA to Reconsider Removal of Lilly’s Obesity Drug From Shortage ListZacks
The FDA has agreed in court to allow compounding pharmacies to continue producing compounded versions of LLY’s tirzepatide while reconsidering the drug’s supply status.
X